Arrowhead Pharmaceuticals, Inc. (ARWR)

65.93 +1.37 (+2.12%) USD  |  NASDAQ  |  Jan 12, 16:00
65.96 +0.03 (+0.05%) After-Hours: 20:00
More

Arrowhead Pharmaceuticals Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Eli Lilly & Co. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Celcuity, Inc. Upgrade